2024 Recap: Your Favorite Alira Health Publications
Our reports, webinars and expert interviews explored emerging and expanding markets in 2024 while also highlighting the need for increased patient engagement throughout the life sciences product lifecycle. Below we share our most popular insights and publications from 2024.
2024 Global Medtech Contract Manufacturing Report
What are the market forces in global medtech contract manufacturing in 2024? We released our annual 2024 Global Medtech Contract Manufacturing Report which investigates the current trends in the fast-growing global medtech outsourcing industry. You can check out the report executive summary and download the 2024 Global Medtech Contract Manufacturing Report to access our insights. Looking for merger and acquisition insights? Review our mid-year update on global medtech contract manufacturing mergers and acquisitions.
2024 Biologics and Advanced Therapies Contract Manufacturing Report
Discover how innovative breakthroughs in cell and gene therapies mark a new phase for transformative therapies nearing commercialization. Examine current industry trends and competitive dynamics in North American and Europe by downloading the 2024 Biologics and Advanced Therapies Contract Manufacturing Report.
Robotic-Assisted Surgery in Orthopedic Procedures: A 2024 Review
Our comprehensive report highlights key trends, emerging technologies, and growth in the global orthopedic robotic-assisted surgery market while providing actionable insights for key market stakeholders. Download Robotic-Assisted Surgery in Orthopedic Procedures: A 2024 Review.
Rather watch and listen? View this on-demand webinar covering the current landscape and outlook for robotic-assisted surgery in orthopedic procedures.
2024 Global Biosimilars Report
What is driving success and growth in the global biosimilars market? Download the 2024 Global Biosimilars Report for insights on the impact of biosimilar-friendly regulations, mergers and acquisitions, and growth drivers like patent expirations and the need for cost-effective alternatives.
Frequently Asked Questions: Strategic Patient Engagement as a Game Changer for Your Product Success
The goal of patient engagement is to develop a patient-centric product strategy and value proposition for health authorities based on patient experience data. In Frequently Asked Questions: Strategic Patient Engagement as a Game Changer for Your Product Success, our Patient Engagement experts address some of the most popular questions about how to make patient engagement the core of a product development and commercialization strategy.
The Challenges for Medtech in a Complex Regulatory Landscape in 2024
The regulatory landscape for medtech in the European Union is increasingly complex, continuously evolving, and challenging to navigate. To learn more about changes in the regulatory landscape in the United States, the European Union, the United Kingdom, and Switzerland and what manufacturers should consider when developing their regulatory strategies and prioritizing their target markets, we spoke with our regulatory affairs expert Mercè Guerra, The Challenges for Medtech in a Complex Regulatory Landscape in 2024.
Rather watch and listen? You can watch the on-demand webinar Developing an Effective Regulatory Strategy for the Evolving 2024 Medtech Landscape for insights from our regulatory affairs experts.
The Importance of Involving Patients in the Health Technology Assessment Process for Rare Diseases
A patient-centric approach to the Health Technology Assessment opens up significant opportunities for access to innovation, particularly vital in rare diseases. We spoke with our experts about how engaging rare disease patients in the Health Technology Assessment process gives them the opportunity to have a meaningful impact on the outcome. Start reading The Importance of Involving Patients in the Health Technology Assessment Process for Rare Diseases.
Frequently Asked Questions: Nuclear Medicine Market in 2024: Challenges and Opportunities
Nuclear medicine is a complex area of pharmaceuticals, featuring unique and often challenging dynamics, including varied regulatory landscapes, specialized logistics, and high prices. But it’s also an area that presents a significant opportunity. We got expert answers to your questions on the current nuclear medicine landscape. Check out Frequently Asked Questions: Nuclear Medicine Market in 2024: Challenges and Opportunities.
The Advent of Radioligand Therapies: A 2024 Snapshot on Prostate Cancer
You can also download The Advent of Radioligand Therapies: A 2024 Snapshot on Prostate Cancer. This paper provides an overview of the advent of radioligand therapies through the example of metastatic prostate cancer, highlighting clinical and development trends along with selected strategic considerations in key markets.
WHO Model Lists of Essential Medicines: What You Need to Know
Learn more about the best practices in the Essential Medicines List application submission. Start reading WHO Model Lists of Essential Medicines: What You Need to Know. You can also discover how we help our clients with their application by reading this case study, Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List.
Subscribe to our newsletter for the latest news, events, and thought leadership